Business
GlaxoSmithKline hoping to deliver Australia’s next COVID treatment – Sydney Morning Herald
The pharma giant has started the approvals process for a drug similar to what Donald Trump received.

GSK announced last year it plans to close its Melbourne manufacturing site in Boronia at the end of 2022 after 50 years. The companys research on the COVID treatment has all taken place overseas, with Australias low case numbers meaning it is difficult to run trials for treatments here.
Australia is currently focused on the rollout of coronavirus vaccines, but the local biotech sector has long said there needs to be more treatment options for patients who present with the virus – particularly as…
-
Noosa News23 hours ago
New South Wales Blues left to pick up the pieces after fumbling a chance at State of Origin glory
-
Noosa News17 hours ago
Help to make recycling stick
-
Noosa News15 hours ago
Former Darling Downs Zoo employee sheds new light on horrific lion attack on teacher Joanne Cabban
-
Business17 hours ago
Alphabet’s stock looks like a brilliant buy right now